Lipoproteomics II: Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry
- 31 March 2005
- journal article
- Published by Wiley in Proteomics
- Vol. 5 (5), 1431-1445
- https://doi.org/10.1002/pmic.200401010
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapyJournal of Internal Medicine, 2004
- Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromesCurrent Opinion in Cardiology, 2003
- High-density lipoprotein subpopulations in pathologic conditionsThe American Journal of Cardiology, 2003
- HDL in atherosclerosis: actor or bystander?Atherosclerosis Supplements, 2003
- Inflammatory Reactions in the Pathogenesis of AtherosclerosisJournal of Atherosclerosis and Thrombosis, 2003
- ProteinChip Technology: A New and Facile Method for the Identification and Measurement of High-Density Lipoproteins apoA-I and apoA-II and Their Glycosylated Products in Patients with Diabetes and Cardiovascular DiseaseJournal of Proteome Research, 2002
- High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?Autoimmunity Reviews, 2002
- Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 2001
- In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functionsJournal of Lipid Research, 2001
- Proteomics: new perspectives, new biomedical opportunitiesThe Lancet, 2000